-
Dec- 2025 -17 DecemberGlobal Trends
Biotech Acquirer Xoma to Acquire Generation Bio
Xoma Royalty, a company that has recently established a business strategy centered on acquiring distressed biotechnology firms, has secured its…
Read More » -
17 DecemberGlobal Trends
Sanofi Secures Deals for Novel Alzheimer’s Drug and Next-Generation Autoimmune Therapy
On December 15, 2025, Sanofi announced two significant strategic collaborations aimed at strengthening its advanced therapeutic development pipelines. 1. Agreement…
Read More » -
17 DecemberGlobal Trends
Major Pharmaceutical Company Lowers Revenue Forecast, Shares Drop
The global pharmaceutical corporation, Pfizer, has issued a revenue projection for 2026 in the range of $59.5 billion to $62.5…
Read More » -
17 DecemberGlobal Trends
New Biotech Startup Secures $125 Million to Advance Pain Medication
Ambros Therapeutics, a newly launched biotechnology company, debuted with an oversubscribed Series A financing round of $125 million. The firm…
Read More » -
17 December
Launch of Healthcare Technology Innovation Center by Pharmaceutical Giant and University
On December 14, AstraZeneca and Hanoi University of Science and Technology (HUST) officially inaugurated a new Healthcare Innovation Center. The…
Read More » -
17 DecemberLocal Dynamics
Health Ministry Mandates Stricter Enforcement Against Drug and Cosmetic Violations
The Drug Administration of Vietnam (a specialized regulatory body under the Ministry of Health) has issued an official document to…
Read More » -
17 DecemberM&A
Biopharma Firm Finalizes Takeover of French Immuno-Oncology Specialist
The international biopharmaceutical corporation, Ipsen, successfully concluded its purchase of ImCheck Therapeutics on December 15, 2025, in Paris, France. This…
Read More » -
16 December
-
16 DecemberLocal Dynamics
Pharmaceutical Company Declares Highest-Ever Cash Dividend Payout
Hai Phong Pharmaceutical Joint Stock Company (stock code: DPH) has announced its plan to pay a cash dividend for the…
Read More » -
16 DecemberLocal Dynamics
Vietnamese Healthcare Facility Deploys New Generation Diagnostic Imaging Equipment
Phenikaa University Hospital (PhenikaaMec) has officially commissioned the Philips Ingenia Elition X 3 Tesla Magnetic Resonance Imaging (MRI) system. This…
Read More » -
16 DecemberGlobal Trends
Sanofi Signs Potential $1 Billion Deal for Alzheimer’s Antibody Asset
Sanofi has entered into a licensing agreement with Adel, a clinical-stage biotech based in Seoul, South Korea, for the development…
Read More » -
16 DecemberGlobal Trends
Alphyn Biologics Secures $25 Million in Series B Funding
Alphyn Biologics, a US-based biotechnology company, has successfully completed a Series B funding round, raising $25 million. The round was…
Read More » -
16 DecemberGlobal Trends
SOBI Agrees to Acquire Arthrosi Therapeutics
Swedish Orphan Biovitrum (SOBI) has reached an agreement to acquire Arthrosi Therapeutics Inc., a late-stage biotechnology company developing a highly…
Read More » -
16 DecemberM&A
Pharmaceutical Manufacturer Gaelic Labs Acquires Athlone Laboratories
Gaelic Laboratories, a pharmaceutical manufacturer specializing in Beta-Lactam (penicillin) products, has acquired Athlone Laboratories, a developer and manufacturer of oral…
Read More » -
16 December
Strategic Partnership Expanded Between Dren Bio and Sanofi for Next-Generation B-Cell Therapy
Dren Bio, a privately held, clinical-stage biotechnology company, announced an expanded strategic collaboration with Sanofi for the discovery and development…
Read More » -
16 DecemberGlobal Trends
PARP Combination Therapy Expands Treatment Indication in Prostate Cancer
The U.S. Food and Drug Administration (FDA) has granted an expanded approval for a targeted combination therapy for patients with…
Read More » -
16 DecemberGlobal Trends
J&J Multiple Myeloma Drug Regimen Receives Proactive National Priority Review Voucher from the FDA
The U.S. Food and Drug Administration (FDA) has “proactively” awarded Johnson & Johnson (J&J) a Commissioner’s National Priority Voucher (CNPV)…
Read More » -
16 DecemberGlobal Trends
Novel Combination Therapy Gains Initial Approval for Metastatic Breast Cancer Treatment
The U.S. Food and Drug Administration (FDA) recently granted approval for a new combination regimen for patients with unresectable or…
Read More » -
15 DecemberGlobal Trends
National Occupational Health Provider Extends Reach in Florida
Occupational health specialist Concentra (NYSE:CON), a publicly traded company, has expanded its national footprint by establishing a new medical center…
Read More » -
15 DecemberCapability Development
Leadership Competency Diagnosing: Rationale, Objectives, and Process
The pharmaceutical sector has experienced profound and rapid changes in recent years. Globalization, advancements in digital selling, the integration of…
Read More »